Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
AbbVie is defying the market slump thanks to Skyrizi, its immunology powerhouse. But with Johnson & Johnson entering the fray, will AbbVie keep its edge?